Cite
HARVARD Citation
Kamitori, T. et al. (2021). Inotuzumab ozogamicin following allogeneic hematopoietic stem cell transplantation successfully rescued relapse of CD19‐negative acute lymphoblastic leukemia after CAR‐T cell therapy. Pediatric blood & cancer. 68 (5), p. n/a. [Online].